Literature DB >> 20594517

Dural Sinus Thrombosis Complicated with Heparin Induced Thrombocytopenia and Thrombosis (HITT).

S K Lee1, R Willinsky, K Terbrugge.   

Abstract

SUMMARY: A case of dural sinus thrombosis complicated with heparin induced thrombocytopenia and thrombosis (HITT) is presented. Interventional neuroradiologic procedures have potential risks of this devastating complication that is related with heparin. Clinical features and pathophysiologic mechanisms of HITT are discussed.

Entities:  

Year:  2004        PMID: 20594517      PMCID: PMC3572528          DOI: 10.1177/159101990200800114

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  12 in total

Review 1.  Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management.

Authors:  T F Slaughter; C S Greenberg
Journal:  Anesthesiology       Date:  1997-09       Impact factor: 7.892

2.  Neurologic complications in immune-mediated heparin-induced thrombocytopenia.

Authors:  C Pohl; U Harbrecht; A Greinacher; I Theuerkauf; R Biniek; P Hanfland; T Klockgether
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

3.  Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases.

Authors:  M C Kappers-Klunne; D M Boon; W C Hop; J J Michiels; J Stibbe; C van der Zwaan; P J Koudstaal; H H van Vliet
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

4.  Endovascular repair of an extracranial internal carotid artery aneurysm complicated by heparin-induced thrombocytopenia and thrombosis.

Authors:  M R van Sambeek; C M Segeren; L C van Dijk; J A van Essen; D W Dippel; H van Urk
Journal:  J Endovasc Ther       Date:  2000-10       Impact factor: 3.487

5.  A 14-year study of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

6.  Deep vein thrombosis, pulmonary embolism, and the white clot syndrome.

Authors:  S W Melanson; B Silver; M B Heller
Journal:  Am J Emerg Med       Date:  1996-10       Impact factor: 2.469

7.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 8.  Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy.

Authors:  J M Walenga; R L Bick
Journal:  Med Clin North Am       Date:  1998-05       Impact factor: 5.456

9.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors:  G P Visentin; S E Ford; J P Scott; R H Aster
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution.

Authors:  R G Makhoul; C S Greenberg; R L McCann
Journal:  J Vasc Surg       Date:  1986-11       Impact factor: 4.268

View more
  3 in total

1.  A Rare Case of Extensive Cerebral Venous Sinus Thrombosis Complicated by Heparin-Induced Thrombocytopenia.

Authors:  Noman Ahmed Jang Khan; Ashar Farooqi; Mohamed Alsharedi
Journal:  Case Rep Hematol       Date:  2022-06-06

2.  HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia.

Authors:  Megan M J Bauman; Ryan M Naylor; Eelco F Wijdicks
Journal:  J Thromb Thrombolysis       Date:  2021-06-05       Impact factor: 2.300

3.  A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease.

Authors:  Nadia K Waheed; Ahmed H Qavi; Sarah N Malik; Maleeha Maria; Moeen Riaz; Frans P M Cremers; Maleeha Azam; Raheel Qamar
Journal:  Mol Vis       Date:  2012-05-12       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.